Policy | September 28, 2024
India reaffirms commitment to social determinants of health at UNGA
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
India called for stronger investments in health and social equity at G20 Joint Finance-Health Task Force Meeting
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
AMR poses a critical threat to global public health undermining decades of progress made in the field of modern medicine
NMC to continue its efforts to improve and enhance the quality of medical education in the country
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Target identification will commence on 17 September 2024, following the timeline provided in the campaign guidelines
Subscribe To Our Newsletter & Stay Updated
